Last reviewed · How we verify
NCT05256303
Rural Hospital-Level Care at Home for Acutely Ill Adults
NA trial testing Home Hospital care in Infections in 160 participants. Completed in 17 January 2024.
17 December 2023
Quick facts
| Lead sponsor | Brigham and Women's Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 160 |
| Start date | 16 February 2022 |
| Primary completion | 17 December 2023 |
| Estimated completion | 17 January 2024 |
| Sites | 3 locations across Canada, United States |
Drugs / interventions tested
- Home Hospital care
- Traditional Hospital care
Conditions studied
- Infections — all drugs for Infections →
- Heart Failure — all drugs for Heart Failure →
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
- Asthma — all drugs for Asthma →
Sponsor
Brigham and Women's Hospital
Who can join
18 and older, any sex, with Infections or Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study examines the implications of providing hospital-level care in rural homes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hospital-Level Care at Home for Adults Living in Rural Settings: A Randomized Clinical Trial.
Levine DM, Desai MP, Findeisen SM, Blitzer SC, et al · · 2025 · cited 1× · PMID 41324962 · DOI 10.1001/jamanetworkopen.2025.45712
Verify or expand the search:
- PubMed search for NCT05256303
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infections
Currently open trials in the same condition.
- NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
- NCT07189858 — Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada · NA · active not recruiting
- NCT06426147 — L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients) · NA · recruiting
- NCT06911658 — Infectious Complications After Esophagectomy · recruiting
- NCT06145724 — EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1) · NA · recruiting
Other Brigham and Women's Hospital trials
Trials by the same sponsor.
- NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
- NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
- NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
- NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
- NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05256303 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
- Last refreshed: 12 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05256303.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing